N-Carbobenzyloxy-L-valinyl-ganciclovir(CAS: 194154-40-0)

N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) falls under several regulatory guidelines. It should comply with the International Chemical Safety Card (ICSC) and the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). For European markets, it must adhere to REACH regulations. In the U.S., it is subject to FDA and EPA requirements.

Yes, alternatives to N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) include similar ganciclovir derivatives such as N,N-Diisopropyldiethylammonium ganciclovir and N-Carbobenzyloxy-L-valinyl-ganciclovir itself has isomers. Common alternative reagents include other protecting groups like benzyl or methyl groups.

The market trend for N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) is driven by its use in antiviral research and development. Recent studies focus on its role in HIV and herpes virus treatments. The trend shows a growing interest in its analogs due to their enhanced stability and efficacy. Price trends are influenced by supply chain disruptions and demand fluctuations in pharmaceutical markets.

Waste containing N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) should be collected in a sealed container and stored in a cool, dry location away from direct sunlight. It should be disposed of through professional waste disposal services that comply with local hazardous waste regulations. Environmental protection measures include proper labeling and documentation of waste handling procedures.